Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02389647 · ClinicalTrials.gov registry record
Identification of Novel Molecular Markers for Cerebral Ischemia From Patients With Minor and Devastating Ischemic Injury
A clinical trial, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.
- Completed
- Registry status
- 80
- Enrollment target
NCT02389647 is a clinical trial that has completed, run by St. Joseph's Hospital and Medical Center, Phoenix. The registered enrollment target is 80 participants.
The verdict
NCT02389647 has completed, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to use an iatrogenic model of stroke, meaning those strokes inadvertently caused by endovascular coiling of elective aneurysms, to study the biology of stroke in humans.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2015-03 |
| Est. Completion | 2019-10-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02389647
The ClinicalTrials.gov registry entry for NCT02389647 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Joseph's Hospital and Medical Center, Phoenix, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02389647 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02389647 about?
NCT02389647 is a clinical study titled "Identification of Novel Molecular Markers for Cerebral Ischemia From Patients With Minor and Devastating Ischemic Injury". The purpose of this study is to use an iatrogenic model of stroke, meaning those strokes inadvertently caused by endovascular coiling of elective aneurysms, to study the biology of stroke in humans.
What is the current status of trial NCT02389647?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2015-03. Estimated completion is 2019-10-24.
Who is sponsoring clinical trial NCT02389647?
This trial is sponsored by St. Joseph's Hospital and Medical Center, Phoenix, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.